The Forteo Alendronate Comparator Trial

• Status: Completed
• Trial end date: 2003-05-01

Summary

The main purpose of this study is to evaluate the effects of teriparatide with those of alendronate on spine bone mineral density (BMD) and other osteoporosis factors in postmenopausal women with osteoporosis.

• Phase: Phase 4

Details

• Lead Sponsor: Eli Lilly and Company
• Treatments: Alendronate; Calcium; Teriparatide; Vitamin D